Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 4 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 15Head & Neck 5Gastrointestinal 5Lymphoid 4Tumor-Agnostic 1Other neoplasm 1NET 1Myeloid 1Gynecologic 1Endocrine 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Uterine Cervical Neoplasms 1Anemia 1

Interventions

Epoetin Alfa 8ferric carboxymaltose 6epoetin beta 6Meropenem 6Ceftazidime 5Vancomycin 4Darbepoetin alfa 4apixaban 3Enoxaparin 3Ciprofloxacin 3Cefepime 3iron isomaltoside 1000 2ferrous sulfate 2ferrous fumarate 2Teicoplanin 2Radiotherapy 2Levofloxacin 2Filgrastim 2Dalteparin 2Cholecalciferol 2Aspirin 2Amikacin 2sotorasib 1posaconazole 1ferrous succinate 1ferric gluconate 1eltrombopag 1ceftolozane, tazobactam drug combination 1Vitamin B 12 1Vaccination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Cisplatin × Classical hematology × Clear all
NCT00046969 2013-05-30

Epoetin Beta in Treating Anemia in Patients With Cervical Cancer

National Cancer Institute (NCI)

Phase 4 Completed
450 enrolled
Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡